These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21136284)

  • 41. Statin therapy in heart failure: for good, for bad, or indifferent?
    De Gennaro L; Brunetti ND; Correale M; Buquicchio F; Caldarola P; Di Biase M
    Curr Atheroscler Rep; 2014 Jan; 16(1):377. PubMed ID: 24277654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of statins in heart failure: beyond its cholesterol-lowering effect.
    Kurian KC; Rai P; Sankaran S; Jacob B; Chiong J; Miller AB
    J Card Fail; 2006 Aug; 12(6):473-8. PubMed ID: 16911915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-modifying treatments for heart failure: is their use justified?
    Cleland JG; Hutchinson K; Pellicori P; Clark A
    Heart Fail Clin; 2014 Oct; 10(4):621-34. PubMed ID: 25217437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary and secondary prevention of heart failure with statins.
    Udell JA; Ray JG
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):917-26. PubMed ID: 17173505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pleiotropic effects of statin in therapy in heart failure: a review.
    Correale M; Abruzzese S; Greco CA; Concilio M; Biase MD; Brunetti ND
    Curr Vasc Pharmacol; 2014; 12(6):873-84. PubMed ID: 25440594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
    Horwich TB; MacLellan WR; Fonarow GC
    J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A general assessment of the safety of HMG CoA reductase inhibitors (statins).
    Black DM
    Curr Atheroscler Rep; 2002 Jan; 4(1):34-41. PubMed ID: 11772420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statin therapy for primary prevention of cardiovascular disease.
    Taylor FC; Huffman M; Ebrahim S
    JAMA; 2013 Dec; 310(22):2451-2. PubMed ID: 24276813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
    Moonis M; Fisher M
    Expert Rev Neurother; 2004 Mar; 4(2):241-7. PubMed ID: 15853565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protecting the heart: a practical review of the statin studies.
    Ong HT
    MedGenMed; 2002 Dec; 4(4):1. PubMed ID: 12817199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statins and mortality among elderly patients hospitalized with heart failure.
    Foody JM; Shah R; Galusha D; Masoudi FA; Havranek EP; Krumholz HM
    Circulation; 2006 Feb; 113(8):1086-92. PubMed ID: 16490817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Observational studies of statins in heart failure with preserved systolic function.
    Fukuta H; Little WC
    Heart Fail Clin; 2008 Apr; 4(2):209-16. PubMed ID: 18433701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin therapy in heart failure.
    Pham M; Oka RK; Giacomini JC
    Curr Opin Lipidol; 2005 Dec; 16(6):630-4. PubMed ID: 16276240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.
    Lee MMY; Sattar N; McMurray JJV; Packard CJ
    Curr Atheroscler Rep; 2019 Jul; 21(10):41. PubMed ID: 31350612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. All for Statins and Statins for All; An Update.
    Agouridis AP; Elisaf MS; Nair DR; Mikhailidis DP
    Curr Pharm Des; 2016; 22(1):18-27. PubMed ID: 26548311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-lipid effects of statins: emerging new indications.
    Yildirir A; Müderrisoglu H
    Curr Vasc Pharmacol; 2004 Oct; 2(4):309-18. PubMed ID: 15320810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia.
    Waldman A; Kritharides L
    Drugs; 2003; 63(2):139-52. PubMed ID: 12515562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential use of HMG-CoA reductase inhibitors for osteoporosis.
    Cushenberry LM; de Bittner MR
    Ann Pharmacother; 2002 Apr; 36(4):671-8. PubMed ID: 11918519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.